[go: up one dir, main page]

BR0208161A - Forma farmacêutica sólida orodispersìvel - Google Patents

Forma farmacêutica sólida orodispersìvel

Info

Publication number
BR0208161A
BR0208161A BR0208161-0A BR0208161A BR0208161A BR 0208161 A BR0208161 A BR 0208161A BR 0208161 A BR0208161 A BR 0208161A BR 0208161 A BR0208161 A BR 0208161A
Authority
BR
Brazil
Prior art keywords
orodispersibly
dosage form
solid dosage
solid pharmaceutical
orodispersible solid
Prior art date
Application number
BR0208161-0A
Other languages
English (en)
Inventor
Michel Serpelloni
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres filed Critical Roquette Freres
Publication of BR0208161A publication Critical patent/BR0208161A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"FORMA FARMACêUTICA SóLIDA ORODISPERSìVEL". A presente invenção tem como objeto uma forma farmacêutica sólida orodispersível, caracterizada pelo fato de que ela compreende: grânulos que consistem em lactose e amido co-secados, pelo menos uma substância ativa. A invenção também em como objeto a utilização de grânulos que consistem em lactose e amido co-secados na fabricação de formas sólidas farmacêuticas orodispersíveis.
BR0208161-0A 2002-01-18 2002-12-19 Forma farmacêutica sólida orodispersìvel BR0208161A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0200647A FR2834889B1 (fr) 2002-01-18 2002-01-18 Forme pharmaceutique solide orodispersible
PCT/FR2002/004454 WO2003061623A1 (fr) 2002-01-18 2002-12-19 Forme pharmaceutique solide orodispersible

Publications (1)

Publication Number Publication Date
BR0208161A true BR0208161A (pt) 2004-03-02

Family

ID=27589521

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0208161-0A BR0208161A (pt) 2002-01-18 2002-12-19 Forma farmacêutica sólida orodispersìvel

Country Status (22)

Country Link
US (1) US7201922B2 (pt)
EP (1) EP1465593B1 (pt)
JP (1) JP2005515240A (pt)
KR (1) KR100961367B1 (pt)
CN (1) CN1248681C (pt)
AT (1) ATE439828T1 (pt)
AU (1) AU2002364468C1 (pt)
BR (1) BR0208161A (pt)
CA (1) CA2441796A1 (pt)
CZ (1) CZ20032486A3 (pt)
DE (1) DE60233436D1 (pt)
FR (1) FR2834889B1 (pt)
HU (1) HUP0303948A2 (pt)
IL (2) IL158691A0 (pt)
MX (1) MXPA03008420A (pt)
NO (1) NO326259B1 (pt)
NZ (1) NZ529694A (pt)
PL (1) PL209144B1 (pt)
RU (1) RU2317812C2 (pt)
SK (1) SK287812B6 (pt)
WO (1) WO2003061623A1 (pt)
ZA (1) ZA200308664B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
AU1323400A (en) * 1998-10-27 2000-05-15 Fuisz Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
FR2834894B1 (fr) * 2002-01-21 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de piribedil
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
FR2834893B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de perindopril
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
DE10229472A1 (de) * 2002-07-01 2004-01-15 Symrise Gmbh & Co. Kg Kompaktierter Milchsäurementhylester
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
FR2858556B1 (fr) * 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
TWI358407B (en) * 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
KR101109633B1 (ko) 2007-08-03 2012-01-31 제이더블유중외제약 주식회사 활성성분의 코팅막이 보호되는 구강내붕해제형을 제조하기위한 조성물
FR2920311B1 (fr) * 2007-08-31 2010-06-18 Galenix Innovations Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation
EP2397161B1 (en) * 2009-02-12 2019-09-25 Fuji Chemical Industry Co., Ltd. Disintegrating particle composition and rapidly disintegrating compression-molded material comprising same
RU2497505C1 (ru) * 2012-11-07 2013-11-10 Максим Эдуардович Запольский Новая лекарственная композиция для лечения болевого синдрома при спазме гладкой мускулатуры
RU2503447C1 (ru) * 2012-11-20 2014-01-10 Максим Эдуардович Запольский Лекарственное средство в форме ородисперсной таблетки и способ получения лекарственного средства
US20160136091A1 (en) * 2013-07-19 2016-05-19 Sanwa Kagaku Kenkyusho Co., Ltd. Orally Disintegrating Tablet
DE102017103346A1 (de) 2017-02-17 2018-08-23 Lts Lohmann Therapie-Systeme Ag Strukturierte orodispergierbare Filme
JP7138666B2 (ja) * 2018-01-24 2022-09-16 大原薬品工業株式会社 γ－アミノ酪酸誘導体含有錠剤の化学的安定性を改善する方法
MX2023008370A (es) * 2023-07-13 2025-02-10 Posi Visionary Solutions Llp Composicion farmaceutica orodispersable de clonazepam

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327077A (en) * 1981-05-29 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
JP3349535B2 (ja) * 1993-01-12 2002-11-25 フロイント産業株式会社 球形顆粒の製造方法
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
JP4064476B2 (ja) * 1996-03-29 2008-03-19 エラワン ファーマスーティカル リサーチ アンドラボラトリー カンパニー リミテッド 二酸化珪素を有する球状凝集した澱粉
WO1998002185A1 (en) * 1996-07-12 1998-01-22 Daiichi Pharmaceutical Co., Ltd. Quickly disintegrable compression-molded materials and process for producing the same
FR2752162B1 (fr) 1996-08-07 1998-11-06 Jouveinal Lab Comprime de maleate de trimebutine pellicule
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
GB9901819D0 (en) * 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
WO2000057857A1 (en) 1999-03-25 2000-10-05 Yuhan Corporation Rapidly disintegrable tablet for oral administration
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
ES2292414T3 (es) * 2000-07-27 2008-03-16 Roquette Freres Granulos a base de almidon y de lactosa.
AU2001294250A1 (en) * 2000-10-16 2002-04-29 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions quickly disintegrating in the oral cavity and process forproducing the same
FR2823668B1 (fr) * 2001-04-20 2004-02-27 Ethypharm Lab Prod Ethiques Comprimes effervescents orodispersibles
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
AU2002348884A1 (en) * 2001-12-21 2003-07-09 Pfizer Products Inc. Directly compressible formulations of azithromycin
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
JP2005526095A (ja) * 2002-03-20 2005-09-02 エラン ファーマ インターナショナル，リミティド 脆砕性の低い急速溶解投与剤型

Also Published As

Publication number Publication date
ATE439828T1 (de) 2009-09-15
PL362762A1 (en) 2004-11-02
CN1516576A (zh) 2004-07-28
FR2834889B1 (fr) 2004-04-02
ZA200308664B (en) 2004-11-08
NO326259B1 (no) 2008-10-27
JP2005515240A (ja) 2005-05-26
FR2834889A1 (fr) 2003-07-25
CZ20032486A3 (cs) 2004-01-14
AU2002364468B2 (en) 2008-06-26
RU2003128025A (ru) 2005-03-27
MXPA03008420A (es) 2004-03-16
SK11712003A3 (sk) 2004-02-03
NZ529694A (en) 2006-04-28
IL158691A0 (en) 2004-05-12
US20030147947A1 (en) 2003-08-07
HU0303948D0 (en) 2004-01-28
WO2003061623A1 (fr) 2003-07-31
PL209144B1 (pl) 2011-07-29
SK287812B6 (sk) 2011-10-04
EP1465593B1 (fr) 2009-08-19
KR20040073288A (ko) 2004-08-19
AU2002364468C1 (en) 2009-01-22
CN1248681C (zh) 2006-04-05
NO20034139L (no) 2003-11-11
US7201922B2 (en) 2007-04-10
HUP0303948A2 (hu) 2004-04-28
KR100961367B1 (ko) 2010-06-07
EP1465593A1 (fr) 2004-10-13
RU2317812C2 (ru) 2008-02-27
IL158691A (en) 2008-08-07
DE60233436D1 (de) 2009-10-01
NO20034139D0 (no) 2003-09-17
CA2441796A1 (fr) 2003-07-31

Similar Documents

Publication Publication Date Title
BR0208161A (pt) Forma farmacêutica sólida orodispersìvel
BR0307072A (pt) Composição farmacêutica orodispersìvel de agomelatina
ATE514418T1 (de) Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan
EA200800064A1 (ru) Композиция в виде гранул с модифицированным и немедленным высвобождением мемантина
BRPI0410503A (pt) uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição
UA89798C2 (ru) Стабильный водный препарат антитела в гистидинацетатном буфере
BR0013826A (pt) Formas orais de apresentação
DK1372608T3 (da) Medicinske aerosolformuleringer
PT1077680E (pt) Metodo de fabrico de uma forma de dosagem de agente activo com bandas de libertacao prolongada
BR0307056A (pt) Composição farmacêutica orodispersìvel de ivabradina
TW200501947A (en) Stabilized pharmaceutical composition comprising an amorphous active substance
ATE286664T1 (de) Pharmazeutische oder diätetische zusammensetzungen aus pilzen und deren verwendung
BRPI0311700B8 (pt) processo para a produção de uma preparação em forma de película e preparação em forma de película
BRPI0418378A (pt) combinações de substáncias ativas com propriedades inseticidas
MXPA06010767A (es) Composicion farmaceutica anhidra que asocia un agente siliconado y principio activo solubilizado.
AR021405A1 (es) Composiciones de beta-lactama
BR0307048A (pt) Composição farmacêutica orodispersìvel de perindoprila
DE10253150B4 (de) Elektrisches Saitenmusikinstrument mit Befestigungsmitteln, die gemeinsam vom Rahmenkörper und einem Gurt verwendet werden
ITMI20022394A1 (it) Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
BR0314787A (pt) Forma de dosagem de liberação modificada
DE602004014787D1 (de) Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln
BRPI0412706A (pt) composição farmacêutica orodispersìvel de um composto antitrombótico
CY1110841T1 (el) Σταθεροποιημενος φαρμακευτικος παραγοντας λευκοτριενιου β4 (ltb4)
DE60323138D1 (de) Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
SE0000303D0 (sv) Novel compounds

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2285 DE 21/10/2014.

B08E Application fees: payment of additional fee required [chapter 8.5 patent gazette]

Free format text: COMPLEMENTAR A RETRIBUICAO DA 9A E 10A ANUIDADES, DE ACORDO COM TABELA VIGENTE, REFERENTE AS GUIAS DE RECOLHIMENTO 22100962941-1 E 22111234344-4 RESPECTIVAMENTE E COMPROVAR O RECOLHIMENTO DA 12A ANUIDADE.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AO NAO CUMPRIMENTO DO DESPACHO 8.5 NA RPI 2292 DE 09/12/2014

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2308 DE 31/03/2015.